Protective effects of dexmedetomidine combined with flurbiprofen axetil on remifentanil-induced hyperalgesia: A randomized controlled trial

Yu,Zenggui; Wu,Weilan; Wu,Xiaodan; Lei,Hongyi; Gong,Cansheng; Xu,Shiyuan

doi:10.3892/etm.2016.3687

Protective effects of dexmedetomidine combined with flurbiprofen axetil on remifentanil-induced hyperalgesia: A randomized controlled trial

Authors:
- Zenggui Yu
- Weilan Wu
- Xiaodan Wu
- Hongyi Lei
- Cansheng Gong
- Shiyuan Xu
View Affiliations

Affiliations: Department of Anesthesiology, Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong 510280, P.R. China, Department of Anesthesiology, Fujian Provincial Hospital, Fuzhou, Fujian 350001, P.R. China
Published online on: September 8, 2016 https://doi.org/10.3892/etm.2016.3687
Pages: 2622-2628
Copyright: © Yu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

High dosages of intra‑operative remifentanil are associated with opioid‑induced hyperalgesia (OIH). The aim of the present study was to investigate the effect of combined dexmedetomidine and flurbiprofen axetil treatment on remifentanil‑induced hyperalgesia. Patients with an American Society of Anesthesiologists physical status of I‑II who were diagnosed with hysteromyoma and scheduled for laparoscopic assisted vaginal hysterectomy (LAVH) were randomly divided into three groups. Group hyperalgesia (Group H, n=29) received intra‑operative remifentanil, Group hyperalgesia and dexmedetomidine (Group HD, n=28) received remifentanil and a continuous infusion of dexmedetomidine, and Group hyperalgesia, dexmedetomidine and flurbiprofen axetil (Group HDF, n=29) received remifentanil, flurbiprofen axetil and dexmedetomidine. Mechanical pain thresholds were measured during the preoperative visit and postoperatively at 1, 6 and 24‑h time points. Visual analog scale (VAS) scores, time to analgesic requirement, total sufentanil consumption and side effects were assessed postoperatively. Mechanical pain threshold at the incision site was significantly lower in Group H compared with Groups HD and HDF (both P<0.05), and significantly higher in Group HDF than in Group HD (P<0.05). The area of secondary hyperalgesia at the incision site was greater in Group H than in the other two groups (both P<0.05), and significantly smaller in Group HDF compared with Group HD (P<0.05). VAS scores and total sufentanil consumption were significantly higher in Group H compared with the other two groups (both P<0.05), and were significantly lower in Group HDF compared with Group HD (P<0.05). Dexmedetomidine combined with flurbiprofen axetil exhibits synergetic effects in the prevention of remifentanil‑induced hyperalgesia in patients undergoing LAVH.

View Figures

View References

1	Wu CL and Raja SN: Treatment of acute postoperative pain. Lancet. 377:2215–2225. 2011. View Article : Google Scholar : PubMed/NCBI
2	Angst MS and Clark JD: Opioid-induced hyperalgesia: A qualitative systematic review. Anesthesiology. 104:570–587. 2006. View Article : Google Scholar : PubMed/NCBI
3	Fletcher D and Martinez V: Opioid-induced hyperalgesia in patients after surgery: A systematic review and a meta-analysis. Br J Anaesth. 112:991–1004. 2014. View Article : Google Scholar : PubMed/NCBI
4	Lee M, Silverman SM, Hansen H, Patel VB and Manchikanti L: A comprehensive review of opioid-induced hyperalgesia. Pain Physician. 14:145–161. 2011.PubMed/NCBI
5	Zhao M and Joo DT: Enhancement of spinal N-methyl-D-aspartate receptor function by remifentanil action at delta-opioid receptors as a mechanism for acute opioid-induced hyperalgesia or tolerance. Anesthesiology. 109:308–317. 2008. View Article : Google Scholar : PubMed/NCBI
6	Chu LF, Angst MS and Clark D: Opioid-induced hyperalgesia in humans: Molecular mechanisms and clinical considerations. Clin J Pain. 24:479–496. 2008. View Article : Google Scholar : PubMed/NCBI
7	Zheng Y, Cui S, Liu Y, Zhang J, Zhang W, Zhang J, Gu X and Ma Z: Dexmedetomidine prevents remifentanil-induced postoperative hyperalgesia and decreases spinal tyrosine phosphorylation of N-methyl-d-aspartate receptor 2B subunit. Brain Res Bull. 87:427–431. 2012. View Article : Google Scholar : PubMed/NCBI
8	Tröster A, Sittl R, Singler B, Schmelz M, Schüttler J and Koppert W: Modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by parecoxib in humans. Anesthesiology. 105:1016–1023. 2006. View Article : Google Scholar : PubMed/NCBI
9	O'Rielly DD and Loomis CW: Increased expression of cyclooxygenase and nitric oxide isoforms, and exaggerated sensitivity to prostaglandin E2, in the rat lumbar spinal cord 3 days after L5-L6 spinal nerve ligation. Anesthesiology. 104:328–337. 2006. View Article : Google Scholar : PubMed/NCBI
10	Ahmadi S, Muth-Selbach U, Lauterbach A, Lipfert P, Neuhuber WL and Zeilhofer HU: Facilitation of spinal NMDA receptor currents by spillover of synaptically released glycine. Science. 300:2094–2097. 2003. View Article : Google Scholar : PubMed/NCBI
11	Joly V, Richebe P, Guignard B, Fletcher D, Maurette P, Sessler DI and Chauvin M: Remifentanil-induced postoperative hyperalgesia and its prevention with small-dose ketamine. Anesthesiology. 103:147–155. 2005. View Article : Google Scholar : PubMed/NCBI
12	Blaudszun G, Lysakowski C, Elia N and Tramèr MR: Effect of perioperative systemic α2 agonists on postoperative morphine consumption and pain intensity: Systematic review and meta-analysis of randomized controlled trials. Anesthesiology. 116:1312–1322. 2012. View Article : Google Scholar : PubMed/NCBI
13	Gu X, Wu X, Liu Y, Cui S and Ma Z: Tyrosine phosphorylation of the N-Methyl-D-Aspartate receptor 2B subunit in spinal cord contributes to remifentanil-induced postoperative hyperalgesia: The preventive effect of ketamine. Mol Pain. 5:762009. View Article : Google Scholar : PubMed/NCBI
14	Faber ES, Chambers JP and Evans RH: Depression of NMDA receptor-mediated synaptic transmission by four alpha2 adrenoceptor agonists on the in vitro rat spinal cord preparation. Br J Pharmacol. 124:507–512. 1998. View Article : Google Scholar : PubMed/NCBI
15	Kimura M, Saito S and Obata H: Dexmedetomidine decreases hyperalgesia in neuropathic pain by increasing acetylcholine in the spinal cord. Neurosci Lett. 529:70–74. 2012. View Article : Google Scholar : PubMed/NCBI
16	Xu B, Zhang WS, Yang JL, Lû N, Deng XM, Xu H and Zhang YQ: Evidence for suppression of spinal glial activation by dexmedetomidine in a rat model of monoarthritis. Clin Exp Pharmacol Physiol. 37:e158–e166. 2010. View Article : Google Scholar : PubMed/NCBI
17	Liu L, Ji F, Liang J, He H, Fu Y and Cao M: Inhibition by dexmedetomidine of the activation of spinal dorsal horn glias and the intracellular ERK signaling pathway induced by nerve injury. Brain Res. 1427:1–9. 2012. View Article : Google Scholar : PubMed/NCBI
18	Lee C, Kim YD and Kim JN: Antihyperalgesic effects of dexmedetomidine on high-dose remifentanil-induced hyperalgesia. Korean J Anesthesiol. 64:301–307. 2013. View Article : Google Scholar : PubMed/NCBI
19	Singler B, Tröster A, Manering N, Schüttler J and Koppert W: Modulation of remifentanil induced postinfusion hyperalgesia by propofol. Anesth Analg. 104:1397–1403. 2007. View Article : Google Scholar : PubMed/NCBI
20	Ohmukai O: Lipo-NSAID preparation. Adv Drug Deliv Rev. 20:203–207. 1996. View Article : Google Scholar
21	Baba H, Kohno T, Moore KA and Woolf CJ: Direct activation of rat spinal dorsal horn neurons by prostaglandin E2. J Neurosci. 21:1750–1756. 2001.PubMed/NCBI
22	Wen ZH, Chang YC, Cherng CH, Wang JJ, Tao PL and Wong CS: Increasing of intrathecal CST excitatory amino acids concentration following morphine challenge in morphine-tolerant rats. Brain Res. 995:253–259. 2004. View Article : Google Scholar : PubMed/NCBI
23	Li SQ, Xing YL, Chen WN, Yue SL, Li L and Li WB: Activation of NMDA receptor is associated with up-regulation of COX-2 expression in the spinal dorsal horn during nociceptive inputs in rats. Neurochem Res. 34:1451–1463. 2009. View Article : Google Scholar : PubMed/NCBI
24	Lenz H, Raeder J, Draegni T, Heyerdahl F, Schmelz M and Stubhaug A: Effects of COX inhibition on experimental pain and hyperalgesia during and after remifentanil infusion in humans. Pain. 152:1289–1297. 2011. View Article : Google Scholar : PubMed/NCBI
25	Akbari E: The role of cyclo-oxygenase inhibitors in attenuating opioid-induced tolerance, hyperalgesia, and dependence. Med Hypotheses. 78:102–106. 2012. View Article : Google Scholar : PubMed/NCBI
26	Koppert W, Wehrfritz A, Körber N, Sittl R, Albrecht S, Schüttler J and Schmelz M: The cyclooxygenase isozyme inhibitors parecoxib and paracetamol reduce central hyperalgesia in humans. Pain. 108:148–153. 2004. View Article : Google Scholar : PubMed/NCBI
27	Tröster A, Sittl R, Singler B, Schmelz M, Schüttler J and Koppert W: Modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by parecoxib in humans. Anesthesiology. 105:1016–1023. 2006. View Article : Google Scholar : PubMed/NCBI
28	Hinrichs-Rocker A, Schulz K, Järvinen I, Lefering R, Simanski C and Neugebauer EA: Psychosocial predictors and correlates for chronic post-surgical pain (CPSP)-a systematic review. Eur J Pain. 13:719–730. 2009. View Article : Google Scholar : PubMed/NCBI
29	Rolke R, Baron R, Maier C, Tölle TR, Treede RD, Beyer A, Binder A, Birbaumer N, Birklein F, Bötefür IC, et al: Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): Standardized protocol and reference values. Pain. 123:231–243. 2006. View Article : Google Scholar : PubMed/NCBI
30	Lee C, Lee HW and Kim JN: Effect of oral pregabalin on opioid-induced hyperalgesia in patients undergoing laparo-endoscopic single-site urologic surgery. Korean J Anesthesiol. 64:19–24. 2013. View Article : Google Scholar : PubMed/NCBI
31	Tena B, Escobar B, Arguis MJ, Cantero C, Rios J and Gomar C: Reproducibility of Electronic Von Frey and Von Frey monofilaments testing. Clin J Pain. 28:318–323. 2012. View Article : Google Scholar : PubMed/NCBI
32	Bajwa SJ, Gupta S, Kaur J, Singh A and Parmar S: Reduction in the incidence of shivering with perioperative dexmedetomidine: A randomized prospective study. J Anaesthesiol Clin Pharmacol. 28:86–91. 2012. View Article : Google Scholar : PubMed/NCBI
33	Elmawgood AA, Rashwan S and Rashwan D: Effect of parecoxib on remifentanil induced postoperative shivering. Egypt J Anaesthesiol. 30:399–403. 2014. View Article : Google Scholar